Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PIM-3 kinase as a target for type 2 diabetes mellitus

PIM-3 kinase as a target for type 2 diabetes mellitus

US Patent 7629126 · Granted Dec 8, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Insulin derivatives having an extremely delayed time-action profile2017
Oxathiazine derivatives substituted with carbocycles or heterocycles, method for2014
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs con2014
Tetrasubstituted oxathiazine derivatives, method for producing them, their use a2014
Oxathiazine derivatives which are substituted with benzyl or heteromethylene gro2014
Di- and tri-substituted oxathiazine derivatives, method for the production there2014
Branched oxathiazine derivatives, method for the production thereof, use thereof2014
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs con2014
Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, me2014
Di and tri- substituted oxathiazine derivatives, method for the production, meth2014
Insulin derivatives having an extremely delayed time-action profile2014
PIM-3 kinase as a target for type 2 diabetes mellitus2013